Lilly Breast Cancer Drug Wins Expanded U.S. Approval Lilly Breast Cancer Drug Wins Expanded U.S. Approval

U.S. regulators have approved expanded use of Eli Lilly and Co ' s Verzenio breast cancer drug as an initial treatment for certain women with advanced or metastatic disease, a decision that should boost sales of the medicine, the company said on Monday.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Alert Source Type: news